关注
Christoph Zielinski
Christoph Zielinski
Professor of Medical Oncology, Medical University Vienna
在 meduniwien.ac.at 的电子邮件经过验证
标题
引用次数
引用次数
年份
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
T Ciuleanu, T Brodowicz, C Zielinski, JH Kim, M Krzakowski, E Laack, ...
The Lancet 374 (9699), 1432-1440, 2009
15452009
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ...
European journal of cancer 47 (1), 8-32, 2011
12462011
Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3
DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...
Journal of Clinical Oncology 36 (24), 2465-2472, 2018
9792018
Prediction of venous thromboembolism in cancer patients
C Ay, D Dunkler, C Marosi, AL Chiriac, R Vormittag, R Simanek, ...
Blood, The Journal of the American Society of Hematology 116 (24), 5377-5382, 2010
9142010
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical …
NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ...
Annals of Oncology 26 (8), 1547-1573, 2015
8872015
Trastuzumab beyond progression in human epidermal growth factor receptor 2–positive advanced breast cancer: a German Breast Group 26/Breast International Group 03-05 study
G von Minckwitz, A du Bois, M Schmidt, N Maass, T Cufer, FE de Jongh, ...
Journal of Clinical Oncology 27 (12), 1999-2006, 2009
8622009
Therapeutic vaccines for cancer: an overview of clinical trials
I Melero, G Gaudernack, W Gerritsen, C Huber, G Parmiani, S Scholl, ...
Nature reviews Clinical oncology 11 (9), 509-524, 2014
8402014
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
V Subbiah, RJ Kreitman, ZA Wainberg, JY Cho, JHM Schellens, JC Soria, ...
Journal of Clinical Oncology 36 (1), 7-13, 2018
8182018
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma
M Schmidinger, CC Zielinski, UM Vogl, A Bojic, M Bojic, C Schukro, ...
Journal of clinical oncology 26 (32), 5204-5212, 2008
7002008
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and …
MS Aapro, DA Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, ...
European journal of cancer 42 (15), 2433-2453, 2006
6612006
Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment
WJ Köstler, M Hejna, C Wenzel, CC Zielinski
CA: a cancer journal for clinicians 51 (5), 290-315, 2001
6282001
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
AS Berghoff, B Kiesel, G Widhalm, O Rajky, G Ricken, A Wöhrer, ...
Neuro-oncology 17 (8), 1064-1075, 2015
5992015
ESMO-magnitude of clinical benefit scale version 1.1
NI Cherny, U Dafni, J Bogaerts, NJ Latino, G Pentheroudakis, ...
Annals of oncology 28 (10), 2340-2366, 2017
5812017
D-dimer and prothrombin fragment 1+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study
C Ay, R Vormittag, D Dunkler, R Simanek, AL Chiriac, J Drach, ...
Journal of Clinical Oncology 27 (25), 4124-4129, 2009
5452009
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
B Gruenberger, D Tamandl, J Schueller, W Scheithauer, C Zielinski, ...
Journal of clinical oncology 26 (11), 1830-1835, 2008
5402008
Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer
M Reck, A Luft, A Szczesna, L Havel, SW Kim, W Akerley, MC Pietanza, ...
Journal of Clinical Oncology 34 (31), 3740-3748, 2016
5282016
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
C Ay, R Simanek, R Vormittag, D Dunkler, G Alguel, S Koder, G Kornek, ...
Blood, The Journal of the American Society of Hematology 112 (7), 2703-2708, 2008
5152008
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial
T Brodowicz, M Krzakowski, M Zwitter, V Tzekova, R Ramlau, N Ghilezan, ...
Lung cancer 52 (2), 155-163, 2006
4742006
High D-dimer levels are associated with poor prognosis in cancer patients
C Ay, D Dunkler, R Pirker, J Thaler, P Quehenberger, O Wagner, ...
haematologica 97 (8), 1158, 2012
4442012
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
F Andre, CC Zielinski
Annals of oncology 23, vi46-vi51, 2012
3912012
系统目前无法执行此操作,请稍后再试。
文章 1–20